🔎 Trials Near Me

Akèy › Kadyomiopati › Virginia

Etid klinik pou Kadyomiopati nan Virginia

7 etid pou Kadyomiopati ap chèche patisipan nan sit nan Virginia.

Vil nan Virginia

Tèks ofisyèl etid la (Anglè)

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  • Clinical Trial Site, Charlottesville
  • Clinical Trial Site, Falls Church
  • Clinical Trial Site, Norfolk
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

  • Inova Schar Cancer, Fairfax
  • Inova Health Care Service, Falls Church
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07023666

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • INOVA Fairfax Hospital, Falls Church
  • Virginia Commonwealth University, Richmond
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

  • Children's Hospital of Richmond at VCU, Richmond
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 28, 2026 · NCT07674758

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  • INOVA Fairfax Hospital, Falls Church
  • Virginia Commonwealth University - Department of Internal Medicine, Richmond
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

  • Virginia Commonwealth University School of Medicine, Richmond
Ap rekriteEtid obsèvasyon
Laj 18 a 85 · Tout sèks · Mizajou Jan 20, 2026 · NCT00733590

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

  • Virginia Commonwealth University, Richmond
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2025 · NCT06964464

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.